The Current Ratio as of November 2024 (TTM) for Axcella Health Inc. (AXLA) is 0.80

According to Axcella Health Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.80. This represents a change of -25.32% compared to the average of 1.08 of the last 4 quarters.

Axcella Health Inc. (AXLA) Historical Current Ratio (quarterly & annually)

How has AXLA Current Ratio performed in the past?

The mean historical Current Ratio of Axcella Health Inc. over the last ten years is 8.72. The current 0.80 Current Ratio has changed 821.29% with respect to the historical average. Over the past ten years (40 quarters), AXLA's Current Ratio was at its highest in in the September 2020 quarter at 21.60. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Axcella Health Inc. (AXLA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Axcella Health Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axcella Health Inc. (AXLA) Average Current Ratio

How has AXLA Current Ratio performed in the past?

The current Current Ratio of Axcella Health Inc. (AXLA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Axcella Health Inc. (AXLA) Current Ratio vs. Peers

How is AXLA’s Current Ratio compared to its peers?

Axcella Health Inc.’s Current Ratio is less than Cyclerion Therapeutics, Inc. (3.68), less than Magenta Therapeutics, Inc. (14.64), less than Kezar Life Sciences, Inc. (9.58), greater than ContraFect Corporation (0.53), greater than Panbela Therapeutics, Inc. (0.05), less than CytomX Therapeutics, Inc. (1.00), greater than Aridis Pharmaceuticals, Inc. (0.37), less than Neoleukin Therapeutics, Inc. (15.33), less than Assembly Biosciences, Inc. (2.74), less than Instil Bio, Inc. (15.06), less than Nuvation Bio Inc. (11.49), greater than Akari Therapeutics, Plc (0.58), less than Salarius Pharmaceuticals, Inc. (2.98), less than Histogen Inc. (4.05), less than RenovoRx, Inc. (4.39), less than Adial Pharmaceuticals, Inc. (5.69), greater than Better Therapeutics, Inc. (0.57), less than Pasithea Therapeutics Corp. (6.20),

Build a custom stock screener for Axcella Health Inc. (AXLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axcella Health Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axcella Health Inc. (AXLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axcella Health Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.